Stereotaxis gains CE Mark for MAGiC catheter, boosting revenue with high margins. FDA approval expected soon. Click here to ...

Asian stocks were mostly up Friday, on the back of a near-record rally on U.S. stocks as investors paid little attention to U.S. President Donald Trump’s latest tariff threats ...

Asian stock markets mostly traded higher on Thursday as traders responded to higher-than-expected US inflation data.

Indian equity markets open lower due to global trade concerns, metal stocks decline, Nifty faces resistance, FIIs sell, RBI ...

Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market ... relate to stock selection in China.

The rise of China's DeepSeek AI model is boosting Chinese tech firms including Alibaba, Baidu, and Xiaomi.

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

As China directs its large financial institutions to help revive and rebalance a struggling stock market, analysts see merit ...

President Donald Trump signed a memo Thursday directing his administration to start determining what level of reciprocal ...

Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...

Asian equities were mixed but mostly lower overnight as Korea and Japan outperformed and Hong Kong and Mainland China ...

Shares to rise on mixed US jobs report; Trump plans further tariffs; Ansell earnings, sales grow in H1; the Aussie rises.